Intermittent
claudication
refers to aching or squeezing pain in thighs, buttocks or feet during exercise,
due to insufficient blood circulation resulting from peripheral arterial
disease. The probability of developing peripheral arterial disease increases
with the age.
Request
to Get Free Sample Pages at:
Smoking,
high blood pressure, atherosclerosis, diabetes, and high cholesterol are some
of the risk factors associated with the development of peripheral arterial
disease, resulting in intermittent claudication. Intermittent claudication is
detected by the pulse and blood pressure in legs and by arteriogram. The
standard treatments available for intermittent claudication are angioplasty and
surgery.
Request
to Get Free Sample Pages at:
Pluristem Ltd. is in the process of developing
PLX-PAD for the treatment of intermittent claudication associated with
peripheral arterial disease. Some of the companies involved in intermittent
claudication pipeline include Kowa Company Ltd., and Nissan Chemical Industries
Ltd. Among others.
The report
provides a comprehensive understanding of the pipeline activities covering all
drug candidates under various stages of development, with the detailed analysis
of pipeline and clinical trials.
Pipeline
analysis of drugs by phases includes product description and development
activities including information about clinical results, designations,
collaborations, licensing, grants, technology, and others.
No comments:
Post a Comment